5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid

C46H73N13O13 — CID 102295371

IUPAC5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid
SMILESNC(N)=NCCC[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCNC(=O)CCC(C(=O)O)N2CCCN3CCN(CCCN(CC(=O)O)CC3)CC2)NC1=O
InChIInChI=1S/C46H73N13O13/c47-46(48)50-15-3-7-32-42(68)53-33(43(69)54-34(26-30-8-10-31(60)11-9-30)44(70)55-35(27-39(63)64)41(67)51-28-38(62)52-32)6-1-2-14-49-37(61)13-12-36(45(71)72)59-19-5-17-56-20-21-57(24-25-59)16-4-18-58(23-22-56)29-40(65)66/h8-11,32-36,60H,1-7,12-29H2,(H,49,61)(H,51,67)(H,52,62)(H,53,68)(H,54,69)(H,55,70)(H,63,64)(H,65,66)(H,71,72)(H4,47,48,50)/t32-,33-,34+,35-,36?/m0/s1
InChIKeyGVISQZHIFWQPAP-CQYLDSTOSA-N
MW1016.17 g/mol
LogP-3.85
Rot. Bonds20

About 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid

5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid (PubChem CID 102295371) has the molecular formula C46H73N13O13 and a molecular weight of 1016.17 g/mol. Its IUPAC name is 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid.

Molecular Properties

Compound Name5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid
PubChem CID102295371
Molecular FormulaC46H73N13O13
Molecular Weight1016.17 g/mol
Exact Mass1015.55
IUPAC Name5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid
SMILESNC(N)=NCCC[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCNC(=O)CCC(C(=O)O)N2CCCN3CCN(CCCN(CC(=O)O)CC3)CC2)NC1=O
InChIInChI=1S/C46H73N13O13/c47-46(48)50-15-3-7-32-42(68)53-33(43(69)54-34(26-30-8-10-31(60)11-9-30)44(70)55-35(27-39(63)64)41(67)51-28-38(62)52-32)6-1-2-14-49-37(61)13-12-36(45(71)72)59-19-5-17-56-20-21-57(24-25-59)16-4-18-58(23-22-56)29-40(65)66/h8-11,32-36,60H,1-7,12-29H2,(H,49,61)(H,51,67)(H,52,62)(H,53,68)(H,54,69)(H,55,70)(H,63,64)(H,65,66)(H,71,72)(H4,47,48,50)/t32-,33-,34+,35-,36?/m0/s1
InChIKeyGVISQZHIFWQPAP-CQYLDSTOSA-N
XLogP-3.85
TPSA384.09 Ų
H-Bond Donors12
H-Bond Acceptors15
Rotatable Bonds20
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001016.17
LogP ≤ 5-3.85
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid?
The IUPAC name of 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid (CID 102295371) is 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid.
What is the SMILES notation for 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid?
The canonical SMILES for 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid is NC(N)=NCCC[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCNC(=O)CCC(C(=O)O)N2CCCN3CCN(CCCN(CC(=O)O)CC3)CC2)NC1=O.
What is the InChIKey of 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid?
The InChIKey is GVISQZHIFWQPAP-CQYLDSTOSA-N. The full InChI is InChI=1S/C46H73N13O13/c47-46(48)50-15-3-7-32-42(68)53-33(43(69)54-34(26-30-8-10-31(60)11-9-30)44(70)55-35(27-39(63)64)41(67)51-28-38(62)52-32)6-1-2-14-49-37(61)13-12-36(45(71)72)59-19-5-17-56-20-21-57(24-25-59)16-4-18-58(23-22-56)29-40(65)66/h8-11,32-36,60H,1-7,12-29H2,(H,49,61)(H,51,67)(H,52,62)(H,53,68)(H,54,69)(H,55,70)(H,63,64)(H,65,66)(H,71,72)(H4,47,48,50)/t32-,33-,34+,35-,36?/m0/s1.
What are the key properties of 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid?
5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid has a molecular weight of 1016.17 g/mol, XLogP of -3.85, 20 rotatable bonds, 12 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[(2S,5R,8S,14S)-8-(carboxymethyl)-14-[3-(diaminomethylideneamino)propyl]-5-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[11-(carboxymethyl)-1,4,8,11-tetrazabicyclo[6.6.2]hexadecan-4-yl]-5-oxopentanoic acid is sourced from PubChem (CID 102295371), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).